James N Luo
Overview
Explore the profile of James N Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
231
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joseph J, Baby H, Quintero J, Kenney D, Mebratu Y, Bhatia E, et al.
Adv Mater
. 2024 Sep;
36(46):e2406348.
PMID: 39318086
Nasal sprays for pre-exposure prophylaxis against respiratory infections show limited protection (20-70%), largely due to their single mechanism of action-either neutralizing pathogens or blocking their entry at the nasal lining,...
2.
Lee S, Zhao S, Jiang W, Chen X, Zhu L, Joseph J, et al.
bioRxiv
. 2024 Sep;
PMID: 39253509
Achieving ultra-long-term release of hydrophilic drugs over several months remains a significant challenge for existing long-acting injectables (LAIs). Existing platforms, such as forming implants (ISFI), exhibit high burst release due...
3.
Gao J, Gunasekar S, Xia Z, Shalin K, Jiang C, Chen H, et al.
Nat Rev Neurosci
. 2024 Jun;
25(8):553-572.
PMID: 38898231
Gene therapy is emerging as a powerful tool to modulate abnormal gene expression, a hallmark of most CNS disorders. The transformative potentials of recently approved gene therapies for the treatment...
4.
Joshi N, Yan J, Dang M, Slaughter K, Wang Y, Wu D, et al.
bioRxiv
. 2024 Jun;
PMID: 38826308
Intra-articular delivery of disease-modifying osteoarthritis drugs (DMOADs) is likely to be most effective in early post-traumatic osteoarthritis (PTOA) when symptoms are minimal and patients are physically active. DMOAD delivery systems...
5.
Joseph J, Baby H, Zhao S, Li X, Cheung K, Swain K, et al.
Exploration (Beijing)
. 2023 Jun;
2(6):20210038.
PMID: 37324804
Respiratory pathogens transmit primarily through particles such as droplets and aerosols. Although often overlooked, the resuspension of settled droplets is also a key facilitator of disease transmission. In this review,...
6.
Gao J, Xia Z, Vohidova D, Joseph J, Luo J, Joshi N
Acta Pharm Sin B
. 2023 May;
13(4):1400-1428.
PMID: 37139423
Emerging therapies based on localized delivery of siRNA to lungs have opened up exciting possibilities for treatment of different lung diseases. Localized delivery of siRNA to lungs has shown to...
7.
Gao J, Xia Z, Mary H, Joseph J, Luo J, Joshi N
Trends Pharmacol Sci
. 2022 Jan;
43(3):171-187.
PMID: 35086691
Despite four decades of research in intra-articular drug delivery systems (DDS) and two decades of advances in disease-modifying osteoarthritis drugs (DMOADs), there is still no clinically available disease-modifying therapy for...
8.
Luo J, Tavakkoli A
Surg Clin North Am
. 2021 Mar;
101(2):223-237.
PMID: 33743966
Bariatric and metabolic surgery has evolved from simple experimental procedures for a chronic problem associated with significant morbidity into a sophisticated multidisciplinary treatment modality rooted in biology and physiology. Although...
9.
Chaudhari S, Luo J, Harris D, Aliakbarian H, Yao L, Paik D, et al.
Cell Host Microbe
. 2021 Jan;
29(3):408-424.e7.
PMID: 33434516
Bariatric surgery is the most effective treatment for type 2 diabetes and is associated with changes in gut metabolites. Previous work uncovered a gut-restricted TGR5 agonist with anti-diabetic properties-cholic acid-7-sulfate...
10.
Chaudhari S, Harris D, Aliakbarian H, Luo J, Henke M, Subramaniam R, et al.
Nat Chem Biol
. 2020 Aug;
17(1):20-29.
PMID: 32747812
Bariatric surgery, the most effective treatment for obesity and type 2 diabetes, is associated with increased levels of the incretin hormone glucagon-like peptide-1 (GLP-1) and changes in levels of circulating...